There are several types of SMA.


There are several types of SMA, occurring in humans, depending on their age that to appear to appear Lorson believes that the introduction of the missing gene through the central nervous system. Is one way to potentially treat no matter what SMA type SMA type.

– Born ‘Typically mice with SMA only live five or six days, but the introduction of the missing SMN gene in the mouse central nervous system, we were able to to extend their lives longer than 10-25 days SMA mice untreated untreated Lorson Lorson, MU MU Bond Life Sciences Center and the College of Veterinary Medicine. ‘at system system is not perfect, which has to show in our study that the direct administration of the missing gene in the central nervous system a certain amount rescue and a deep extension of the survival time. ‘.

Along with many other pharmaceutical manufacturer Teva is named in numerous civil lawsuits, the drug price reporting system sourced from the manufacturers in approximately 15 countries. The cases are pending in federal and state courts, generally allege that the prices reported by pharmaceutical companies caused governments to pay inflated reimbursements for drugs under Medicaid or other programs.NICE Recommended on Alzheimer drug – ABPI statementThe Union of British Pharmaceutical Industry today welcomed the redesigned position to Alzheimer’s drugs expressed in NICE in expressing disappointment at their value does not for people with mild Alzheimer’s still not recognized were.

Of course’While the decision is permit to patients with moderate Alzheimer’s treat with these agents, of course, welcome, it is was disappointing that her potential value in the patients to its mildest forms the disease was not recognized,’Barker said. ‘All to do to in order to avoid or at least be to slow develop this distressing condition priority of priority for health care.. REFERENCES: Janice K. Public Health Medical Officer, California Department of Public Healthcare, Edward Walsh, a professor, medicine, University of Rochester Medical Centre, and Chief, Infectious Diseases, in Rochester General Hospital, New York, Scott Lillibridge, Associate Dean, Texas A & M Health Sciences Center School of Rural Public Health, in Houston, Jeffrey Boscamp, medical-in-chief, Sanzari hospital for Children, Hackensack University Medical Center intensive care 3rd November 2009, teleconference with: Thomas Frieden, Director of, U.S.